Presentation TCT 2014 The REG1 Anticoagulation System: Factor IX Inhibitor Using RNA Aptamer Technology Presenter: A. Michael Lincoff September 15, 2014 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2014 Up Next Presentation TCT 2014 TCT 149: Intracoronary Injection of Bone Marrow-Derived Mononuclear Cells, Early or Late After Acute Myocardial Infarction: Long-term Effects on Global Left Ventricular Function Twelve-Month MRI and Long-term Clinical Results of the SWISS-AMI Trial Presenter: Daniel Suerder, MD September 15, 2014 More slides + Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk Presenter: Bo Xu September 15, 2014 Presentation TCT 2014 Yes, It Is a Good Option for Most Anticoagulation Eligible Patients Presenter: Saibal Kar September 15, 2014 We Recommend
Presentation TCT 2014 TCT 149: Intracoronary Injection of Bone Marrow-Derived Mononuclear Cells, Early or Late After Acute Myocardial Infarction: Long-term Effects on Global Left Ventricular Function Twelve-Month MRI and Long-term Clinical Results of the SWISS-AMI Trial Presenter: Daniel Suerder, MD September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk Presenter: Bo Xu September 15, 2014
Presentation TCT 2014 Yes, It Is a Good Option for Most Anticoagulation Eligible Patients Presenter: Saibal Kar September 15, 2014